These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1243 related items for PubMed ID: 7599749

  • 1. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 2. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA.
    Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046
    [Abstract] [Full Text] [Related]

  • 3. Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.
    Sigurdsson A, Amtorp O, Gundersen T, Nilsson B, Remes J, Swedberg K.
    Br Heart J; 1994 Nov 26; 72(5):422-7. PubMed ID: 7818958
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 26; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 5. Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling.
    Sigurdsson A, Held P, Swedberg K, Wall B.
    Eur Heart J; 1993 Aug 26; 14(8):1110-7. PubMed ID: 8404942
    [Abstract] [Full Text] [Related]

  • 6. Effect of ACE inhibition on neurohormones.
    Remme WJ.
    Eur Heart J; 1998 Sep 26; 19 Suppl J():J16-23. PubMed ID: 9796836
    [Abstract] [Full Text] [Related]

  • 7. [Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
    Fujiwara M, Asakuma S, Nakamura T, Nakamura K, Iwasaki T.
    J Cardiol; 1995 Nov 26; 26(5):287-92. PubMed ID: 8523261
    [Abstract] [Full Text] [Related]

  • 8. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
    Rodríguez JA, Godoy I, Castro P, Quintana JC, Chávez E, Yovanovich J, Corbalán R, Chávez A.
    Rev Med Chil; 1997 Jun 26; 125(6):643-52. PubMed ID: 9515282
    [Abstract] [Full Text] [Related]

  • 9. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, Yoshikawa J.
    Int J Clin Pharmacol Ther; 1997 Jan 26; 35(1):38-42. PubMed ID: 9021441
    [Abstract] [Full Text] [Related]

  • 10. [Effect of angiotensin converting enzyme inhibitor lisinopril on sympathetic heart rate response during exercise in the early phase of acute myocardial infarction].
    Akashi Y, Tanabe K, Osada N, Samejima H, Seki A, Yokoyama Y, Nakayama M, Suzuki N, Oomiya K, Itoh H, Miyake F, Murayama M.
    J Cardiol; 2000 Oct 26; 36(4):221-9. PubMed ID: 11079227
    [Abstract] [Full Text] [Related]

  • 11. Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.
    Davidson NC, Coutie WJ, Webb DJ, Struthers AD.
    Heart; 1996 Jun 26; 75(6):576-81. PubMed ID: 8697160
    [Abstract] [Full Text] [Related]

  • 12. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M, Lauri G, Melzi G, Cattadori G, Agostoni P.
    Cardiologia; 1996 Jun 26; 41(6):527-33. PubMed ID: 8766415
    [Abstract] [Full Text] [Related]

  • 13. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G, Vecchio C.
    G Ital Cardiol; 1994 Jan 26; 24(1):59-70. PubMed ID: 8200499
    [Abstract] [Full Text] [Related]

  • 14. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
    Tsuyuki RT, Yusuf S, Rouleau JL, Maggioni AP, McKelvie RS, Wiecek EM, Wang Y, Pogue J, Teo KK, White M, Avezum A, Latini R, Held P, Lindgren E, Probstfield J.
    Can J Cardiol; 1997 Dec 26; 13(12):1166-74. PubMed ID: 9444298
    [Abstract] [Full Text] [Related]

  • 15. [Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor].
    Pomini G, Rugna A, Lupia M, Opocher G, Gribaldo R.
    G Ital Cardiol; 1992 Jul 26; 22(7):807-12. PubMed ID: 1473654
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB.
    Cardiol Clin; 1995 Aug 26; 13(3):379-90. PubMed ID: 7585774
    [Abstract] [Full Text] [Related]

  • 17. Effects of ramipril on the neurohormonal response to exercise in patients with mild or moderate congestive heart failure.
    Sigurdsson A, Swedberg K, Ullman B.
    Eur Heart J; 1994 Feb 26; 15(2):247-54. PubMed ID: 8005128
    [Abstract] [Full Text] [Related]

  • 18. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).
    Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H.
    N Engl J Med; 1992 Sep 03; 327(10):678-84. PubMed ID: 1495520
    [Abstract] [Full Text] [Related]

  • 19. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A, Swedberg K.
    Eur Heart J; 1995 Dec 03; 16 Suppl N():65-72. PubMed ID: 8682064
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS, Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators.
    Am J Cardiol; 2005 Sep 01; 96(5):698-704. PubMed ID: 16125499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.